Surgical Correction for Clubfoot
Treatment for Congenital musculoskeletal and limb anomalies
Typical Dosage: Single surgical procedure
Effectiveness
80%
Safety Score
62%
Clinical Trials
1
Participants
20K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
62
DangerousModerateSafe
Treatment Details
Dosage Range
Single surgical procedure
Time to Effect
Immediate anatomical correction, recovery 6-12 weeks
Treatment Duration
One-time surgery, followed by casting/bracing for several months
Evidence Quality
MODERATEConfidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$1,500
Side Effect Mgmt:$500
Total Annual:$18,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
MODERATEICER
$80,000/QALY
QALYs Gained
0.6
Outcome-Based Costs
Cost per Responder
$22,500
Cost per Remission
$25,714.29
Comparison vs Ponseti Method
Cost Difference
+$16,900/year
More expensive
QALY Difference
-0.20 QALYs
Worse outcomes
Dominance
No dominance
Surgical Correction for Clubfoot Outcomes
for Congenital musculoskeletal and limb anomalies
Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+80%
Remission Rate
+70%
Common Side Effects
Infection
+5%
Scarring
+15%
Stiffness/Pain
+10%
Overcorrection/Undercorrection
+8%
Anesthesia complications
+2%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
1 active trial recruiting for Surgical Correction for Clubfoot in Congenital musculoskeletal and limb anomalies
Prospective Evaluation of Treatment for Clubfoot
NCT02257229RECRUITING
2.5K participants
OBSERVATIONAL
Dallas, United States
Started: Aug 1, 2005